PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Articles|August 5, 2011
Zeta Plus Encapsulated Filter System
The Zeta Plus Encapsulated Filter System from diversified technology company 3M is a disposable depth filtration system for cell culture clarification or downstream impurity removal.
Advertisement
The Zeta Plus Encapsulated Filter System from diversified technology company 3M is a disposable depth filtration system for cell culture clarification or downstream impurity removal. It consists of a small system suited to lab or pilot scale production and a large system for production scale biomanufacturing. Both comprise a filter holder, disposable manifolds, and a flexible number of capsule filters. The ergonomically designed large filter holder can be pivoted between the horizontal and vertical position to allow convenient loading and unloading at waist height, as well as minimal footprint during filtration and reduced fluid spills. Two capsule configurations are available for use with the system: the 0.23 m2 capsule is designed for use with the small holder and the 1.6 m2 capsule is designed for use with both holders, offering a high degree of process flexibility. The latter has a CAM locking mechanism for a fast, easy, robust capsule-to-capsule connection.
Advertisement
Related to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Advertisement
Advertisement